Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EP Biocomposites's ROE % for the quarter that ended in Mar. 2026 was 24.06%. EP Biocomposites's PB Ratio for the quarter that ended in Mar. 2026 was 1.17.
EP Biocomposites's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 20.56%.
EP Biocomposites ROE % Adjusted to Book Value Related Terms
EP Biocomposites ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for EP Biocomposites's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EP Biocomposites ROE % Adjusted to Book Value Chart
BOM:543595 vs TT, JCI, CARR: ROE % Adjusted to Book Value Comparison
For the Building Products & Equipment subindustry, EP Biocomposites's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EP Biocomposites ROE % Adjusted to Book Value vs Construction Industry
For the Construction industry and Industrials sector, EP Biocomposites's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where EP Biocomposites's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 20.56% mean?
EP Biocomposites (BOM:543595) has a ROE % Adjusted to Book Value of 20.56% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on EP Biocomposites and its competitors.
Is EP Biocomposites' ROE % Adjusted to Book Value too high?
EP Biocomposites' current ROE % Adjusted to Book Value is 20.56%. Overall, EP Biocomposites has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EP Biocomposites' ROE % Adjusted to Book Value compare to TT and JCI?
EP Biocomposites' ROE % Adjusted to Book Value of 20.56% can be compared against companies in the Construction industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Construction company?
A good ROE % Adjusted to Book Value depends on the Construction industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on EP Biocomposites and its competitors. EP Biocomposites's current ROE % Adjusted to Book Value is 20.56%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EP Biocomposites stock overvalued right now?
Based on GuruFocus' analysis, EP Biocomposites (BOM:543595) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹201.91, compared to a current price of ₹106.00 — trading 47.5% below its estimated fair value. The current ROE % Adjusted to Book Value is 20.56%. EP Biocomposites' overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For EP Biocomposites (BOM:543595), the current ROE % Adjusted to Book Value is 20.56% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EP Biocomposites (BOM:543595) Overvalued in 2026?
Based on GuruFocus' analysis, EP Biocomposites stock appears to be undervalued.
The current stock price of ₹106.00 is trading 47.5% below its estimated GF Value™ of ₹201.91.
GuruFocus considers EP Biocomposites to be Significantly Undervalued.
Key valuation signals for BOM:543595:
ROE % Adjusted to Book Value: 20.56%
GF Value™: ₹201.91 vs. price of ₹106.00 (47.5% below fair value)
No single metric tells the full story. See the BOM:543595 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EP Biocomposites Ltd is the manufacturer and supplier of fibre reinforced polymers products such as door shutters, frames, Biodigestor Tanks, Bio toilets and allied products for construction and Industrial applications. The company focus on giving sanitation solutions to those who do not have access to toilets, as well as to those who have toilets but face trouble treating and managing the waste through septic tanks. The company also provides sanitation infrastructure and human waste management solutions and services, involving simple bio-digester technology licensed from the Defence Research and Development Organisation (DRDO) and Industry Interface and Technology Management, operating under the aegis of DRDO, Ministry of Defence, Government of India.
76GF Score
Get the complete analysis for BOM:543595
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543595 has been successfully added to your 
